Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
Abstract: The shift to a horizontally integrated from a vertically integrated structure in the power system leads to heightened uncertainty across multiple levels. The incorporation of uncertain ...
Abstract: Three-dimensional integrated circuits (3-D ICs) enable a higher level of device integration for high-performance computing but also introduce significant thermal challenges due to increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results